Trademark Overview
On Tuesday, May 13, 2025, a trademark application was filed for NEVIA with the United States Patent and Trademark Office. The USPTO has given the NEVIA trademark a serial number of 99183535. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Thursday, November 6, 2025. This trademark is owned by Enteronova Medical Technologies Inc.. The NEVIA trademark is filed in the Computer & Software Products & Electrical & Scientific Products, Medical Instrument Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Providing online non-downloadable software using artificial intelligence (AI) technology for managing gastrointestinal and inflammatory conditions through transcutaneous cervical vagus nerve stimulation (tcVNS) and transcutaneous auricular vagus nerve stimulation (taVNS); Providing online non-downloadable software for providing and tracking braingut axis treatment sessions, providing personalized gut health recommendations, monitoring progress, and interfacing with wearable medical devices
Downloadable mobile application software for providing and optimizing neuromodulation therapy for gut health; Downloadable computer software using artificial intelligence (AI) technology for managing gastrointestinal and inflammatory conditions through transcutaneous cervical vagus nerve stimulation (tcVNS) and transcutaneous auricular vagus nerve stimulation (taVNS); Downloadable computer software for providing and tracking brain-gut axis treatment sessions, providing personalized gut health recommendations, monitoring progress, and interfacing with wearable medical devices
Providing online digital medical services in the field of gastroenterology, namely, personalized therapeutic support in the nature of remote monitoring for inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) delivered through guided neuromodulation therapy using artificial intelligence (AI) technology for medical diagnosis and treatment purposes; Medical consultation and monitoring services for individuals with gut conditions using transcutaneous cervical and auricular vagus nerve stimulation delivered via wearable devices and mobile applications; Healthcare services, namely, gut-health treatment featuring the integration of bioelectronic therapy, symptom tracking, and real-time treatment adjustment to support immune modulation and inflammation reduction
Non-invasive wearable gut-health medical devices for therapeutic neuromodulation, namely, devices that apply simultaneous transcutaneous cervical vagus nerve stimulation (tcVNS) and transcutaneous auricular vagus nerve stimulation (taVNS) for the treatment of inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), Crohn's Disease, and ulcerative colitis; Medical apparatuses, namely, biofeedback sensors using artificial intelligence (AI) technology featuring dual-modality vagus nerve stimulation for modulating immune function and reducing gut inflammation
